- Article published:
- July 27, 2006, 1:00 BST
- Cyclingnews staff
By Cyclingnews staff After the UCI announced yesterday that one rider had an A sample positive in...
By Cyclingnews staff
After the UCI announced yesterday that one rider had an A sample positive in the 2006 Tour de France, there has been strong speculation about the identity of the rider. The UCI will not confirm the name of the rider until the B sample results come back, but that could be within the week.
Under the Tour de France doping controls, at the end of each stage, the stage winner and yellow jersey wearer are tested, plus at least two random selections, as well as two reserves. It's understood the turn-around for the doping tests is usually within a week.
The UCI said that the rider, his team, his federation, his national anti-doping organisation, and the World Anti-Doping Agency have all been informed. So far, the federations of Belgium, Germany, France, Italy and Spain have all denied being contacted by the UCI. Yesterday, USA Cycling federation also denied being contacted by the UCI, while Cycling Australia has also not been contacted by the UCI in regard to the Tour de France.
However, the UCI's announcement has led to a wildfire of speculation in Europe, leading to a de facto process of elimination to identify the rider.
"The adverse analytical finding received this morning relates to the first analysis, and will have to be confirmed either by a counter analysis required by the rider, or by the fact that the rider renounces that counter analysis," said the UCI in a statement.
Various newspapers have carried speculative articles, claiming the postive result was from a stage in the final week of the Tour.
The Times newspaper is reporting that the positive was for testosterone, and occurred after Stage 17 to Morzine, won by Floyd Landis (Phonak). The yellow jersey was retained on that stage by Oscar Pereiro (Caisse...